Susquehanna International Group, LLP Pulmonx Corp Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$9.88 - $14.0 $184,756 - $261,800	18,700 New	18,700 $193,000
Q1 2023 May 16, 2023	BUY	$7.49 - $12.54 $1.19 Million - $1.99 Million	158,500 Added 1182.84%	171,900 $1.92 Million
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $3,936 - $13,880	800 Added 6.35%	13,400 $112,000
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $193,410 - $302,274	12,600 New	12,600 $210,000
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $638,126 - $1.08 Million	30,200 New	30,200 $749,000
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $662,756 - $1.01 Million	-22,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $802,353 - $991,903	22,300 New	22,300 $802,000
Q2 2021 Aug 11, 2021	SELL	$37.61 - $48.0 $191,811 - $244,800	-5,100 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $224,400 - $344,454	5,100 New	5,100 $233,000

124

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $230M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.